Teva Pharmaceutical's total assets for Q2 2026 were $39.86B, a decrease of -0.46% from the previous quarter. MX:TEVAN total liabilities were $32.10B for the fiscal quarter, a 0.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.